Soft tissue and uterine leiomyosarcoma Journal Article


Authors: George, S.; Serrano, C.; Hensley, M. L.; Ray-Coquard, I.
Article Title: Soft tissue and uterine leiomyosarcoma
Abstract: Leiomyosarcoma (LMS) is one of the most common subtypes of soft tissue sarcoma in adults and can occur in almost any part of the body. Uterine leiomyosarcoma is the most common subtype of uterine sarcoma. Increased awareness of this unique histology has allowed for the development of drugs that are specific to LMS and has begun to shed light on the similarities and possible unique aspects of soft tissue and uterine LMS. In this review, we summarize the current understanding of the epidemiology, diagnosis, genomics, and treatment options for LMS. Copyright © 2018 American Society of Clinical Oncology. All rights reserved.
Keywords: cancer chemotherapy; clinical trial; histopathology; review; systemic therapy; cancer adjuvant therapy; antineoplastic agent; cancer diagnosis; cancer incidence; cancer immunotherapy; metastasis; aromatase inhibitor; cancer therapy; cancer hormone therapy; genomics; leiomyosarcoma; disease predisposition; adjuvant radiotherapy; uterus sarcoma; cancer prognosis; human; priority journal
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 2
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-01-10
Start Page: 144
End Page: 150
Language: English
DOI: 10.1200/jco.2017.75.9845
PROVIDER: scopus
PMCID: PMC5759317
PUBMED: 29220301
DOI/URL:
Notes: Review -- Export Date: 1 February 2018 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Martee L Hensley
    211 Hensley